hematologic malignacy
Conditions
Interventions
Group A:haploidentical/mismatched transplant
Group B:HLA-matched sibling transplant
Group C:unrelated donor transplant
Sponsors
the First Affiliated Hospital of Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
No minimum to 60 Years
Inclusion criteria
Inclusion criteria: 1. hematologic malignanciesto WHO criteria; 2. Age: less than 60 years old; 3. Physical score 0~2 (WHO); 4. Sign the informed consent document.
Exclusion criteria
Exclusion criteria: 1. Aged above 60 years; 2. Contradiction of HSCT, e.g. uncontrolled active infection and severe cardiac, hepatic, renal and pulmonary disease; 3. Pregnant; 4. Mental disorder; 5. Physical score>3 (WHO); 6. Cann't sign the informed consent document.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall survival;relapse rate;PFS;aGVHD;Mortality during 100 days post-HSCT; | — |
Countries
China
Contacts
Public ContactHuang He
Outcome results
None listed